Ignite Creation Date:
2025-12-24 @ 7:19 PM
Ignite Modification Date:
2026-01-01 @ 3:50 AM
Study NCT ID:
NCT02609503
Status:
COMPLETED
Last Update Posted:
2024-11-05
First Post:
2015-11-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-16
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-20
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-12
First Submit QC Date:
None
Study First Post Date:
2015-11-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-01-05
Results First Submit QC Date:
None
Results First Post Date:
2021-03-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-10
Last Update Post Date:
2024-11-05
Last Update Post Date Type:
ACTUAL